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Objectives: To investigate he in vivo haemodynamic performance and neurological outcome of two types of carotid 
shunt. 
Design: Randomised single surgeon study of consecutive symptomatic patients. 
Setting: 163 consecutive patients undergoing carotid endarterectomy for symptomatic carotid isease were randomised 
to the Javid Or Pruitt shunt. 
Chief outcome measures: Middle cerebral artery velocity (MCA V), preoperatively, during clamping, during shunting 
and post-restoration f flow, embolic episodes, neurological outcome. 
Main results: The MCA V preoperatively, at carotid clamping, and postoperatively was the same for both groups (p>0.15). 
During shunting the MCAV was significantly lower in the Pruitt group, p<O.O05. 59% of the Javid and 34% of the 
Pruitt shunts maintained MCA V at preoperative levels p<O.O05, )~2= 8.92. The Javid shunt produced significantly more 
emboli (73% of cases) at declamping than the Pruitt (41%), p<O.O002, Z2= 14.7. Four Javid patients and one Pruitt had 
disabling thromboembolic strokes; overall thromboembolic stroke rate 3.7%. The difference in stroke rates was not 
statistically significant (p = 0.14). 
Conclusions: The Pruitt shunt was unable to maintain preoperative MCAV in 66% of cases, the Javid shunt had a 
higher incidence of emboli on declamping. These factors may lead to an increased risk of stroke; however, the numbers 
required for statistical confirmation would be large. 
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Introduction 
The use of intraluminal shunts during carotid en- 
darterectomy has been an established practice for three 
decades to protect at risk patients from hypoperfusion 
injury. 1"2 Their use remains controversiaP because 
many surgeons feel the incidence of air and ather- 
omatous embolisation, 4 and intimal damage s'6 out- 
weighs any protective value in maintaining cerebral 
perfusion. 7.
A useful shunt must maintain sufficient blood flow 
within the internal carotid artery to prevent ischaemia, 
be minimally traumatic to the native vessels, and give 
rise to as few emboli as possible. Shunt design is 
known to have a critical effect on internal carotid 
artery blood flow; in the animal model and in laborat- 
ory studies some shunts have been shown to function 
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as a severe stenosis producing insufficient blood flow 
to prevent brain ischaemia. 8-1° Some shunt types may 
be associated with a high incidence of gaseous or 
particulate mbolisation, 1~up to 92% in some series; 12 
however, the clinical significance of these events is 
unclear. Thus, shunt design may have a critical effect 
on hypoperfusion, embolisation, and resultant neuro- 
logical outcome, yet there are numerous hunt types 
available with different flow characteristics, gauges, 
and method of fixation within the native vessel. 
The Javid and the Pruitt- Inahara shunts are well 
established, commonly used shunts which have given 
good results in extensive personal series 5'13'14 yet have 
very different design characteristics. The Javid shunt 
is a 32cm long tapered shunt, 17 French gauge prox- 
imally and 10 French distally. It has fusiform swellings 
at each end and is held in place by external clamps. 
The Pruitt- lnahara shunt has a constant gauge of 10 
French, is the same length as the Javid, but is held in 
place by incorporated inflatable balloons at each end. 
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From previous studies we have shown that the 
haemodynamic performance of the two shunt types 
differs significantly. 9"1° Pruitt 13 quotes blood flow rates 
of 180 ml/min through is shunt at a pressure gradient 
of 120mmHg. However, it is our experience that at a 
more physiological pressure gradient of 80mmHg the 
shunt delivers a flow below 100ml/min, less than half 
that delivered by the Javid shunt. In this study we have 
compared these shunts using transcranial Doppler 
monitoring techniques (TCD) to evaluate in vivo the 
effect of shunt design on middle cerebral artery blood 
velocity, shunt associated embolisation, and the re- 
sulting neurological outcome. 
Table 1. Patient demographics and symptoms. 
Patient details Javid (n = 78) Pruitt (n = 85) 
Age, (median, range) 66 yrs (46--79) 66 yrs (37-82) 
Sex (M:F) 61:17 55:30 
Diabetes mellitus 10 (13%) 9 (11%) 
Treated hypertension 41 (53%) 53 (62%) 
Current smoking 20 (26%) 24 (28%) 
Antiplatelet agent 63 (81%) 77 (91%) 
*Full anticoagulation 11 (14%) 5 (6%) 
TIA 54 (69%) 48 (56%) 
Amaurosis 34 (44%) 44 (52%) 
Stroke 23 (29%) 24 (28%) 
* Indicates patients who were warfarinised or on systemic heparin 
preoperatively. 
Patients and Methods 
Between January 1991 and December 1995 163 patients 
(116 men, 47 women) underwent carotid endarter- 
ectomy using a carotid shunt. All were symptomatic 
with transierit ischaemic attacks, amaurosis fugax, or 
recovered stroke. All patients were clinically assessed 
by a neurologist and had colour duplex Doppler and 
digital subtraction arch angiography to assess the se- 
verity and extent of disease in both the ipsilateral and 
contralateral carotid vessels. 
Patients were asked for informed consent o the 
study in accordance with local ethical committee ap- 
proval and randomised by sealed envelope to the Javid 
or Pruitt-Inahara shunt in the anaesthetic room. All 
operations were performed using a standardised tech- 
nique with systemic heparinisation, carotid sinus 
blockade with lignocaine, and under normotensive, 
normocarbic general anaesthetic. Anaesthetic was 
achieved with etomidate, alfentanyl, vecuronium and 
isoflurane with the systolic blood pressure maintained 
within 25 mmHg of baseline (measured as a mean of 
eight measurements taken I day preoperatively onthe 
ward) with infusions of phenylephrine and esmolol 
to increase and decrease the pressure respectively. 
Ipsilateral middle cerebral artery blood velocities 
(MCAV) were monitored throughout the procedure 
using a Transpect ranscranial Doppler (Medsonics, 
California, USA) with a 2 MHz probe fixed over the 
ipsilateral temporal bony window using the technique 
described by Padayachee. 15 Measurements of MCAV 
were taken (mean value over five cardiac cycles) fol- 
lowing anaesthetic nduction prior to surgery, after 
carotid dissection at carotid cross-clamping, after 
shunting had been established, and at the end of the 
procedure after wound closure. Accumulated embolic 
events which lasted more than i s, and the relationship 
of these events with establishment of blood flow 
through the shunt and restoration offlow after emoval 
of the shunt, were recorded. Individual embolic events 
lasting less than i s were not analysed. 
Postoperatively, all patients were placed on anti- 
platelet agents, and underwent neurological assess- 
ment by the operating vascular surgeon 6 weeks fol- 
lowing surgery. All patients were also seen in the 
neurology outpatient clinic between 6 weeks and 3 
months following surgery where they were in- 
dependently assessed as part of the ECST and NA- 
SCET, or as part of our ongoing audit of carotid 
surgery. The neurologist did not have records of which 
shunt was used for the patients urgery. Patients who 
developed new neurological deficits up to 1 month 
postoperatively had computed tomography (CT) of 
the head to establish the nature of the lesion. 
Results 
Eighty-five and 78 patients were randomised to the 
Pruitt and Javid shunts, respectively. Both groups were 
of similar age and sex distribution, had comparable 
incidence of risk factors for vascular disease, and were 
well matched in terms of presenting symptoms (Table 
1). Median ipsilateral stenosis in the Javid group was 
85% (range 55-99), and in the Pruitt was 87% (range 
50-99). Patients undergoing surgery with stenoses of 
less than 70% had been randomised to surgery as 
part of the European Carotid Surgery Trial. Median 
contralateral stenosis in both groups was 50% (range 
30-100 in both cases). 
There was no statistical difference between the two 
groups' blood velocities in the middle cerebral artery 
pre- and postoperatively and at carotid cross-clamping 
(Mann-Whitney). However, during shunting the 
MCAV in the Javid group was significantly higher 
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Table 2. Middle cerebral artery blood velocities (MCAV, cm s 1). 
Javid (n = 73) Pruitt (n = 73) Mann-Whitney 
(2-tailed p-test) 
Median (range) Median (range) 
Pre 38 (3-85) 39 (19-87) 0.43 
Clamp 25 (0-67) 26 (0-73) 0.76 
Shunt 40 (16-109) 33 (12-90) <0.005 
Post 48 (13-120) 52 (15-93) 0.47 
than the MCAV in the Pruitt group (Table 2). In 43 of 
73 Javid patients the shunt was able to restore middle 
cerebral blood velocity to preoperative level (59%), 
whereas only 25 out of 73 Pruitts were able to deliver 
preoperative values (34%). This difference was highly 
significant, p<0.005 (Z 2= 8.92). In 17 (10%) patients (5 
Javid, 12 Pruitt) a temporal bony window was not 
identifiable and Doppler assessment of MCAV and 
embolisation could not be performed. 
At restoration of blood flow following shunt in- 
sertion, 29/73 (40%) of the Javid shunts gave rise to 
embolisation episodes lasting more than i s, compared 
to 23/73 (31%) in the Pruitt group. This difference was 
not significant (p>0.05). At restoration of flow after 
shunt removal there were 53/73 (73%) prolonged em- 
bolisation events in the Javid group compared to 30/ 
73 (41%) in the Pruitt group. This difference was highly 
significant, p= 0.00012 (Z 2 = 14.7). 
Following recovery from general anaesthetic there 
were four CT confirmed disabling thromboembolic 
strokes in the Javid group; two reperfusion haem- 
orrhages into areas of previous infarcts occurred 
within 24 h of surgery (one fatal, the other non-dis- 
abling). One patient had a minor thromboembolic 
neurological deficit apparent immediately post- 
operatively, but this had improved significantly by 
discharge. In all cases of postoperative thrombo- 
embolic neurological deficit there had been prolonged 
embolisation at declamping (Table 3). 
Three Pruitt patients had disabling strokes, one 
thromboembolic stroke was apparent immediately 
following recovery from anaesthesia, one hypo- 
perfusion/watershed infarct, and one reperfusion bled 
into an old infarct occurred within 48 h of surgery. 
There were three minor neurological deficits which 
were apparent immediately postoperatively in the 
Pruitt group, all  of which were improved or resolved 
at one month. In all cases of postoperative n urological 
deficit the shunt MCAV was less than preoperative 
MCAV (Table 3). The difference in disabling throm- 
boembolic stroke rate between the shunt groups failed 
to reach significance (p =0.144). The overall disabling 
stroke rate was 4.9%; disabling thromboembolic stroke 
rate 3.7% and CT proven haemorrhagic stroke rate 
1.2%. In all patients in both groups the endarterectomy 
remained patent at 6 weeks' follow-up. 
In addition to the death from haemorrhagic stroke, 
three Javid patients died before 1 month (two of 
myocardial infarction and one of a pulmonary em- 
bolus). There were no deaths in the Pruitt groups. 
Discussion 
This study has shown that the Pruitt shunt is unable 
to maintain preoperative MCAV in 66% of patients, 
performing like a severe stenosis. In all the cases of 
non-haemorrhagic stroke in the Pruitt group the shunt 
MCAV was below preoperative MCAV levels (Table 
3). As MCAV correlates with cerebral perfusion, 1'16 use 
of the Pruitt shunt may fail to prevent hypoperfusion 
stroke in some patients. Hence the idea that an in- 
dwelling shunt allows the surgeon to perform an 
unhurried endarterectomy may lead to false re- 
assurance if shunt flow is poor. On the other hand, 
given that only 10-20% of patients undergoing carotid 
endarterectomy need a shunt to maintain cerebral 
perfusion, the number of patients in whom the Pruitt 
shunt is inadequate is small. 
Table 3. Relationship of non haemorrhagic strokes to middle cerebral artery velocities and 
embolisation episodes. 
Shunt Stroke severity MCAV (cm s 1) Embolisation 
Pre C lamp Shunt Post Insert Declamp 
Javid Disabling 58 29 51 70 yes yes 
Javid Disabling 39 0 52 49 no yes 
Javid Disabling 43 30 44 47 yes yes 
Javid Disabling 22 14 34 47 no yes 
Javid Minor 44 63 75 120 no yes 
Pruitt Disabling 45 30 42 42 no no 
Pruitt Disabling 58 29 49 72 yes yes 
Pruitt Minor 70 0 30 47 no no 
Pruitt Minor 64 26 51 83 yes no 
Pruitt Minor 60 0 20 80 yes yes 
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It is our experience, and that of Gaunt et a112 and 
Padayachee t al, ~s that short bursts of emboli on TCD 
monitoring following shunt insertion and withdrawal 
is so common as to be considered almost a normal 
event. However,  prolonged episodes must certainly 
be considered pathological. Whilst the Javid shunt 
performed much better than the Pruitt shunt haemo- 
dynamically, it gave rise to significantly more pro- 
longed embolisation events at restoration of internal 
carotid flow. In every case of non-haemorrhagic stroke 
in the Javid group there was prolonged embolisation 
at declamping. However,  prolonged embolisation did 
occur in 73% of the Javid group without clinical se- 
quelae in the majority. 
We feel that the :most likely explanation for the high 
incidence of emboli lies in the Javid clamping system. 
It has been previously noted that external clamping 
of vessels gives rise to greater intimal damage than 
balloon occlusion, I7 leading to the liberation of ather- 
omatous emboli, a problem also noted by other authors 
in association with the Javid shunt. 5'II This problem is 
compounded as the Javid clamps come only in fixed 
sizes regardless of vessel calibre. Although this study 
did not look specifically at vessel damage as a cause 
for emboli, the results do not contradict he idea of 
increased vessel damage with the use of the Javid 
shunt. The increased incidence of emboli in the Javid 
group may lead to an increased incidence of throm- 
boembolic stroke. 
All the three reperfusion strokes occurred early in 
the series in patients with postoperative unstable 
blood pressure (episodes of uncontrolled hypertension 
where systolic pressure reached 200mmHg). These 
patients were initially managed with oral nifedipine 
and beta blockers, but since a policy of managing all 
patients on our high dependency unit for the first 24 h, 
and treating all patients with unstable blood pressure 
with intravenous infusions of beta blockers, we have 
had no further haemorrhagic nfarcts. 
The choice of which shunt to use during carotid 
endarterectomy lies in a balance between haemo- 
dynamic performance and risk of embolisation. Whilst 
our series shows that shunt design has a clear effect 
on haemodynamic performance and embolisation in 
vivo, it must be remembered that because of small 
numbers of adverse outcomes, a study to prove a 
relationship between haemodynamic performance, 
embolisation, and neurological outcome for differing 
shunt types would need to be very large indeed. Our 
study does, however, suggest hat these factors should 
be considered when choosing a shunt. 
The ideal shunt does not exist, but we suggest hat 
it would incorporate a tapered design like the Javid 
for good flow properties, but would be held in place 
by balloons proximally and distally as with the Pruitt 
to reduce intimal damage, in addition to being kink- 
resistant and as short as practically allows. 
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